iRadimed
IRMD
185 hedge funds and large institutions have $492M invested in iRadimed in 2025 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 57 increasing their positions, 67 reducing their positions, and 10 closing their positions.
250% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 10
17% more capital invested
Capital invested by funds: $422M → $492M (+$70.8M)
14% more funds holding
Funds holding: 162 → 185 (+23)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.03% less ownership
Funds ownership: 55.46% → 54.42% (-1%)
15% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 67
87% less call options, than puts
Call options by funds: $107K | Put options by funds: $796K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.57M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$3.34M |
| 3 |
Morgan Stanley
New York
|
+$2.38M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.02M |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$1.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$6.7M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$6.34M |
| 3 |
RC
Roubaix Capital
Denver,
Colorado
|
-$4.27M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$3M |
| 5 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
-$1.63M |
IRMD Hedge Fund Activity: Q3 2025 in Review
185 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2025, worth a combined $492M — up 17% from $422M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new IRMD positions and 10 closed out — a net gain of 25 holders — while 57 added to existing stakes and 67 trimmed.
The largest buyer was BlackRock, adding an estimated $3.57M. The largest seller was Nine Ten Capital Management, cutting an estimated $6.7M.
- 185 institutional investors held iRadimed (IRMD) as of Q3 2025, up from 162 in Q2 2025.
- Funds reported $492M of iRadimed stock for Q3 2025, up 17% quarter-over-quarter.
- 35 funds opened new iRadimed positions in Q3 2025 and 10 closed out, a net change of +25 holders.
- The largest iRadimed buyer in Q3 2025 was BlackRock, an estimated $3.57M added.
- The largest iRadimed seller in Q3 2025 was Nine Ten Capital Management, an estimated $6.7M sold.
Based on aggregated 13F filings for Q3 2025.